[ad_1] VIKEN, Sweden – November 2, 2018 – (Newswire.com) TIKOMED, a specialty pharmaceutical company focused on developing therapeutics for treating acute and degenerative neurological diseases, announced today that the first patient with …
Read More »First Patient Treated With ILB in TIKOMED's Clinical Trial for ALS – Press Release
